PeptideDB

METTL1-WDR4-IN-2 2919742-07-5

METTL1-WDR4-IN-2 2919742-07-5

CAS No.: 2919742-07-5

METTL1-WDR4-IN-2 (compound 6) is a selective METTL1-WDR4 inhibitor with IC50 of 41 μM. METTL1-WDR4-IN-2 shows significa
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

METTL1-WDR4-IN-2 (compound 6) is a selective METTL1-WDR4 inhibitor with IC50 of 41 μM. METTL1-WDR4-IN-2 shows significant selectivity for METTL3-14 and slight selectivity for METTL16.

Physicochemical Properties


CAS # 2919742-07-5
Appearance White to off-white solid powder
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1].Small-Molecule Inhibitors of the m7G-RNA Writer METTL1. ACS Bio Med Chem Au 2023.


Solubility Data


Solubility (In Vitro) DMSO :~100 mg/mL (~196.26 mM; with sonication)
Solubility (In Vivo) Solubility in Formulation 1: 2.5 mg/mL (4.91 mM) in 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one),clear solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared,you can add 100 μL of 25.0 mg/mL clear DMSO stock solution and add it to 400 μL PEG300 and mix well. Then add 50 μL Tween-80 to the above system and mix well. Then continue to add 450 μL of physiological saline to make up to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: 2.5 mg/mL (4.91 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one),clear solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared,you can add 100 μL of 25.0 mg/mL clear DMSO stock solution and add it to 900 μL of 20% SBE-β-CD saline solution and mix well.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: 2.5 mg/mL (4.91 mM) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one),clear solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared,you can add 100 μL of 25.0 mg/mL clear DMSO stock solution and add it to 900 μL corn oil and mix well.

 (Please use freshly prepared in vivo formulations for optimal results.)